AI Identifies Woman’s Early Breast Cancer After Human-Reviewed Mammogram Shows ‘Normal’ Result

Artificial intelligence has achieved a remarkable breakthrough in healthcare, detecting a woman’s breast cancer that had been overlooked in a routine mammogram reviewed by two experienced radiologists. Sheila Tooth, a 68-year-old retired nurse from West Sussex, England, received the all-clear after her mammogram, but thanks to a research project involving AI detection, hidden cancerous cells were found early enough to minimize treatment.

University Hospitals Sussex, where Sheila’s mammogram took place, is part of a pilot project testing AI’s potential to improve cancer detection rates. Using an advanced AI system developed by Kheiron Medical Technologies called Mammography Intelligent Assessment, the program re-analyzed over 12,000 “normal” mammograms, identifying those requiring further examination. The AI suggested a clinical re-evaluation of just under 10% of the mammograms, ultimately detecting five cases of breast cancer among 11 women called back for additional testing.

A Life-Saving Catch for Sheila

Sheila, who had previously been diagnosed with early-stage breast cancer 15 years prior, was shocked yet relieved when the AI detected a recurrence. She underwent a lumpectomy without needing further treatment and expressed deep gratitude for the technology. “I feel so lucky,” she said. “If this had gone undetected, my cancer might have developed into invasive cancer in my 70s.”

AI in Breast Cancer Screening: A Promising Future

According to Dr. Olga Strukowska, a consultant radiologist at the West Sussex Breast Screening Program, the project shows great promise for AI in clinical applications, as it helps radiologists catch potential cancers earlier. “The earlier and more accurately we detect cancer, the better the chances of a positive outcome,” Strukowska said. Similarly, Steve Dixon, Senior AI Project Lead for Breast Services, is optimistic that combining AI with human expertise will enhance patient care and screening accuracy.

The success of the pilot program has paved the way for a national randomized controlled trial on AI-assisted breast cancer screening. With Sheila’s heartfelt endorsement, the hope is that AI will help more women detect breast cancer early, improving outcomes and potentially saving lives.